Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3828308
Max Phase: Preclinical
Molecular Formula: C64H90BrN17O17S
Molecular Weight: 1481.50
Molecule Type: Small molecule
Associated Items:
ID: ALA3828308
Max Phase: Preclinical
Molecular Formula: C64H90BrN17O17S
Molecular Weight: 1481.50
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCCC(=O)NN(CC(=O)N(CC(=O)N(CCOC)CC(=O)N(CCCCN)CC(=O)N(CCCCN)CC(N)=O)NC(=O)c1ccccc1)C(=O)CN(CCCN1CCCC1=O)C(=O)CN(NC(=O)OCC)C(=O)CN(C)C(=O)Cn1nc(-c2ccc(-c3ccc(Br)cc3)s2)oc1=O
Standard InChI: InChI=1S/C64H90BrN17O17S/c1-5-7-19-51(84)69-79(44-60(93)80(70-61(94)46-17-9-8-10-18-46)42-57(90)78(34-35-97-4)39-55(88)76(30-14-12-28-67)38-54(87)75(36-50(68)83)29-13-11-27-66)59(92)40-77(33-16-32-74-31-15-20-52(74)85)56(89)43-81(72-63(95)98-6-2)58(91)37-73(3)53(86)41-82-64(96)99-62(71-82)49-26-25-48(100-49)45-21-23-47(65)24-22-45/h8-10,17-18,21-26H,5-7,11-16,19-20,27-44,66-67H2,1-4H3,(H2,68,83)(H,69,84)(H,70,94)(H,72,95)
Standard InChI Key: PXIHTRHUNLZJFH-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1481.50 | Molecular Weight (Monoisotopic): 1479.5605 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Sarma BK, Liu X, Kodadek T.. (2016) Identification of selective covalent inhibitors of platelet activating factor acetylhydrolase 1B2 from the screening of an oxadiazolone-capped peptoid-azapeptoid hybrid library., 24 (17): [PMID:27160052] [10.1016/j.bmc.2016.04.047] |
Source(1):